{"protocolSection": {"identificationModule": {"nctId": "NCT02983448", "orgStudyIdInfo": {"id": "IRB-7147"}, "organization": {"fullName": "University of Oklahoma", "class": "OTHER"}, "briefTitle": "Noninvasive Neuromodulation to Reserve Diastolic Dysfunction", "officialTitle": "Noninvasive Neuromodulation to Reserve Diastolic Dysfunction", "acronym": "NERDD"}, "statusModule": {"statusVerifiedDate": "2019-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-12", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-11-30", "studyFirstSubmitQcDate": "2016-12-01", "studyFirstPostDateStruct": {"date": "2016-12-06", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-04-19", "resultsFirstSubmitQcDate": "2019-05-20", "resultsFirstPostDateStruct": {"date": "2019-06-11", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-06-13", "lastUpdatePostDateStruct": {"date": "2019-06-25", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Stavros Stavrakis", "investigatorTitle": "Assistant Professor", "investigatorAffiliation": "University of Oklahoma"}, "leadSponsor": {"name": "University of Oklahoma", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "This is a 2x2 cross over pilot study using low level transcutaneous vagus nerve stimulation (LLTS) to reverse diastolic dysfunction in patients with diastolic dysfunction. All patients will receive 2 separate, 1-hour sequences, at least 1 day apart, of active and sham LLTS, but the sequence will be randomized. Patients will be randomly assigned (1:1) to active/sham or sham/active LLTS. LLTS will be performed using a transcutaneous electrical nerve stimulation (TENS) device with electrodes attached to the tragus of the ear, which is innervated by auricular branch of the vagus nerve. Echocardiography will be performed after 30 minutes of LLTS or sham stimulation to assess diastolic function. Five-minute ECGs will be obtained for HRV analysis every 15 minutes of stimulation (total of 4 recordings)."}, "conditionsModule": {"conditions": ["Heart Failure, Diastolic"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "TRIPLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 24, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Sham stimulation first", "type": "PLACEBO_COMPARATOR", "description": "Sham stimulation delivered at the earlobe (devoid of vagal innervation) is given on first session.\n\nTranscutaneous vagus nerve stimulation delivered at the tragus (vagal innervation) is given on second session.", "interventionNames": ["Device: transcutaneous vagus nerve stimulation"]}, {"label": "Active stimulation first", "type": "ACTIVE_COMPARATOR", "description": "Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.\n\nSham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.", "interventionNames": ["Device: transcutaneous vagus nerve stimulation"]}], "interventions": [{"type": "DEVICE", "name": "transcutaneous vagus nerve stimulation", "description": "All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized", "armGroupLabels": ["Active stimulation first", "Sham stimulation first"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Echocardiographic Markers of Diastolic Dysfunction", "description": "Global longitudinal strain", "timeFrame": "after 1 hour of stimulation"}], "secondaryOutcomes": [{"measure": "Heart Rate Variability Measures", "description": "low frequency to high frequency ratio. This is a measure of sympathovagal balance. A lower value reflects a more favorable balance between sympathetic and parasympathetic (vagal) tone.", "timeFrame": "after 1 hour of stimulation"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Male and female patients older than 18 year old\n2. Evidence of diastolic dysfunction on echocardiogram within 24 months of study enrollment\n\nExclusion Criteria:\n\n1. Left ventricular dysfunction (Left ventricular ejection fraction \\<40%)\n2. Significant valvular disorder (i.e., prosthetic valve or hemodynamically relevant valvular diseases)\n3. Recent (\\<6 months) stroke or myocardial infarction\n4. Severe heart failure (NYHA class III or IV)\n5. Recurrent vaso-vagal syncopal episodes\n6. Unilateral or bilateral vagotomy\n7. Pregnancy or breast feeding\n8. Sick sinus syndrome (without a pacemaker), 2nd or 3rd degree AV block, bifascicular block or prolonged (PR\\>300ms) 1st degree AV block", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "90 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "University of Oklahoma Health Sciences Center", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73104", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}]}, "referencesModule": {"references": [{"pmid": "30560316", "type": "DERIVED", "citation": "Tran N, Asad Z, Elkholey K, Scherlag BJ, Po SS, Stavrakis S. Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans. J Cardiovasc Transl Res. 2019 Jun;12(3):221-230. doi: 10.1007/s12265-018-9853-6. Epub 2018 Dec 17."}]}, "ipdSharingStatementModule": {"ipdSharing": "UNDECIDED"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Sham Stimulation First", "description": "Sham stimulation delivered at the earlobe (devoid of vagal innervation) is given on first session.\n\nTranscutaneous vagus nerve stimulation delivered at the tragus (vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}, {"id": "FG001", "title": "Active Stimulation First", "description": "Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.\n\nSham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "All Participants", "description": "All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "24"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "9"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "15"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68.2", "spread": "11.3"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "11"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "13"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "2"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "22"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "24"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Echocardiographic Markers of Diastolic Dysfunction", "description": "Global longitudinal strain", "populationDescription": "All patients received both active and sham transcutaneous vagus nerve stimulation, with the order being randomized. The comparison is between active and sham stimulation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "percent", "timeFrame": "after 1 hour of stimulation", "groups": [{"id": "OG000", "title": "Sham Stimulation", "description": "Sham stimulation delivered at the earlobe (devoid of vagal innervation) is given on first session.\n\nTranscutaneous vagus nerve stimulation delivered at the tragus (vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}, {"id": "OG001", "title": "Active Stimulation", "description": "Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.\n\nSham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-21.2", "spread": "3"}, {"groupId": "OG001", "value": "-23.0", "spread": "2.8"}]}]}]}, {"type": "SECONDARY", "title": "Heart Rate Variability Measures", "description": "low frequency to high frequency ratio. This is a measure of sympathovagal balance. A lower value reflects a more favorable balance between sympathetic and parasympathetic (vagal) tone.", "populationDescription": "All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized. The comparison is between active and sham stimulation.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ratio", "timeFrame": "after 1 hour of stimulation", "groups": [{"id": "OG000", "title": "Sham Stimulation", "description": "All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}, {"id": "OG001", "title": "Active Stimulation", "description": "All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "24"}, {"groupId": "OG001", "value": "24"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.1", "spread": "0.4"}, {"groupId": "OG001", "value": "1.8", "spread": "0.4"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "through study completion (1 week)", "eventGroups": [{"id": "EG000", "title": "Sham Intervention", "description": "Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.\n\nSham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized", "deathsNumAffected": 0, "deathsNumAtRisk": 24, "seriousNumAffected": 0, "seriousNumAtRisk": 24, "otherNumAffected": 0, "otherNumAtRisk": 24}, {"id": "EG001", "title": "Active Intervention", "description": "Transcutaneous vagus nerve stimulation delivered at the earlobe (vagal innervation) is given on first session.\n\nSham stimulation delivered at the tragus (devoid of vagal innervation) is given on second session.\n\ntranscutaneous vagus nerve stimulation: All patients will receive both active and sham transcutaneous vagus nerve stimulation, with the order being randomized", "deathsNumAffected": 0, "deathsNumAtRisk": 24, "seriousNumAffected": 0, "seriousNumAtRisk": 24, "otherNumAffected": 0, "otherNumAtRisk": 24}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Stavros Stavrakis", "organization": "University of Oklahoma Health Sciences Center", "email": "stavros-stavrakis@ouhsc.edu", "phone": "405-271-4742", "phoneExt": "37507"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "ICF", "hasProtocol": false, "hasSap": false, "hasIcf": true, "label": "Informed Consent Form", "date": "2017-11-17", "uploadDate": "2019-04-19T16:33", "filename": "ICF_000.pdf", "size": 347176}, {"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2017-01-10", "uploadDate": "2019-04-19T16:52", "filename": "Prot_SAP_001.pdf", "size": 510877}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000054144", "term": "Heart Failure, Diastolic"}], "ancestors": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "relevance": "LOW"}, {"id": "M27580", "name": "Heart Failure, Diastolic", "asFound": "Heart Failure, Diastolic", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}